17 July 2019 in Neurosurgery
BACKGROUND AND IMPORTANCE: Obsessive-compulsive disorder (OCD) is a disabling psychiatric disorder, mainly treated with psychotherapy and pharmacotherapy. Surgical intervention may be appropriate for patients with treatment-refractory OCD. Deep brain stimulation (DBS) is an alternative for previously common ablative surgical procedures. Tractography has been proposed as a method for individualizing DBS treatment and may have the potential to improve efficacy. CLINICAL PRESENTATION: We present a patient with treatment-refractory OCD previously treated with bilateral leucotomies, who underwent DBS surgery with targeting informed by tractography. Preoperative tractography to identify suitable DBS targets was undertaken. Structural images were also utilized for standard stereotactic surgical planning. The anteromedial globus pallidus internus (amGPi) was chosen as the target bilaterally after consideration of white matter projections to frontal cortical regions and neurosurgical approach. Bilateral amGPi DBS surgery was undertaken without adverse events. At 16-mo follow-up, there was a 48.5% reduction in OCD symptom severity as measured by the Yale-Brown Obsessive Compulsive Scale. CONCLUSION: The amGPi can be a successful DBS target for OCD. This is the first known case to report on DBS surgery postleucotomies for OCD and highlights the utility of tractography for surgical planning in OCD.
1 November 2019 in Journal of Clinical Neuroscience
1 February 2019 in Journal of Clinical Neuroscience
1 November 2020 in World Neurosurgery
1 March 2020 in Journal of Clinical Neuroscience
4 July 2025 in Journal of Clinical Neuroscience
Brain metastases (BMs) occur in 10-20 % of cancer patients and significantly impact mortality in adults. While awake craniotomy (AC) is established as safe for primary brain tumors in eloquent areas, evidence for its use in BMs remains limited. This study evaluates AC versus general anesthesia (GA) for surgical resection of BMs in eloquent brain regions. This retrospective cohort study analyzed 77 patients who underwent surgical resection of BMs at Soroka University Medical Center between 2015-2022. Patients were divided into AC (n = 16) and GA (n = 61) groups. A secondary analysis examined outcomes across three groups: AC, GA with neuromonitoring (n = 21), and GA without neuromonitoring (n = 40). Primary outcomes included postoperative neurological status, overall survival, and hospital length of stay (LOS). The AC group demonstrated significantly better neurological improvement rates at 14 days (93.8 % vs 21.3 %, p < 0.001) and six weeks post-surgery (56.3 % vs 1.6 %, p < 0.001) compared to the GA group. Mean LOS was shorter in the AC group (4.25 vs 7.18 days, p = 0.072), with lower mortality rates (62.5 % vs 83.6 %, p = 0.085). In the three-group analysis, AC showed superior neurological outcomes, with improvement rates at six weeks being 56.3 % for AC, 4.8 % for GA with neuromonitoring, and 0 % for GA without neuromonitoring (p < 0.001). Awake craniotomy demonstrates superior outcomes for resecting BMs in eloquent areas, with significantly better neurological recovery and trends toward shorter LOS and lower mortality. Neuromonitoring improves surgical outcomes, particularly in GA cases. These findings support AC as a preferred approach for appropriately selected patients with BMs in eloquent regions.